sábado, 6 de julio de 2013

Acúfenos: Recomendaciones del comité de expertos en implantes cocleares y dispositivos Implantables de La Federacion Argentina de Sociedades de otorrinolaringología




El “Comité de expertos en implante coclear y dispositivos implantables” de La Federación Argentina de Sociedades de Otorrinolaringología, (FASO)  


Ha publicado en Buenos Aires, con fecha  20 de diciembre de 2011, un conjunto de indicaciones para el uso de implantes cocleares denominado:

"Consenso sobre indicaciones de la utilización de implantes cocleares, de acuerdo a guías internacionales"

Que fue avalado por los siguientes profesionales:
Dr. Santiago Arauz,  Dr. Carlos Boccio, Dr. Leopoldo Cordero; Dr.Carlos Curet; Dr. Vicente Diamante ; Dr. Eduardo Hocsman; Dr. Luis Nicenboim; Dr. Daniel Orfila; Dr. Fernando Romero Orellano; Dr. Héctor Ruiz, Dr. Mario Zernotti.

El consenso puede ser leído completo en la pagina Web de la FASO entrando por la dirección: Http://www.faso.org.ar/imagenes/informe.pdf

Tiene dicho consenso 3 artículos referidos a implante coclear, el N° 3 se refiere a hipoacusia unilateral con acúfenos y dice lo siguiente:

Indicaciones de Implante coclear unilateral


1- Hipoacusia neurosensorial profunda unilateral con un acúfeno incapacitante refractario al tratamiento.

2-  Hipoacusia neurosensorial súbita profunda unilateral



Nota de la redacción

La lectura del punto número 1 de las indicaciones de utilización de implante coclear unilateral avalan su utilización cuando un paciente afectado en un solo oído por una hipoacusia neurosensorial profunda (no reversible)  tenga además un acúfeno que no responde a otros tratamientos (farmacológicos, quirúrgicos, sonoros, psicológicos, etc.)  lo que permite utilizar estas formidables herramientas terapéuticas (los implantes cocleares)  para el tratamiento de este particular subgrupo de pacientes con acúfenos.

Dr. Darío Isaac Roitman
Director del Centro de Acúfenos Buenos Aires.
 C.A.B.A.

Referente a la FASO

La F. A. S. O. (Federación Argentina de Sociedades de Otorrinolaringología) es una institución de Bien Público, sin fines de lucro, fundada el día 25 de Junio del año 1947. Cuenta con su edificio propio en la calle Angel Carranza 2382 de la Ciudad Autónoma de Buenos Aires. 

personería Jurídica Civiles 7555 – Resolución 6315 / 84 Registro Nacional de Entidades de Bien Público N° 2558

ACTIVIDADES

Su principal actividad es la docencia de post grado. Para ello lleva a cabo permanentemente cursos de perfeccionamiento en su sede de Capital Federal (curso anual) y cursos itinerantes en el Interior del país, patrocinados por las sociedades que la comforman.

Cuenta con tres salones de conferencias con una capacidad promedio de 80 asistentes aproximadamente en cada sala. Cada uno de ellos dispuesto con todo el material técnico necesario para llevar a cabo dichas actividades, (proyección de datos y video, doble proyección de diapositivas, videoproyección, retroproyector, audio, pizarrón, etc.)

Posee un laboratorio de microcirugía equipado con siete microscopios, tornos, instrumental, preparados anatómicos y toda la infraestructura que permite llevar a cabo cursos prácticos de distinta temática dentro de la especialidad.

Organiza, en estrecha relación con sus Sociedades Federadas, los Congresos Nacionales de la especialidad que se llevan a cabo cada dos años en las distintas provincias, de acuerdo a un orden preestablecido.

La F.A.S.O., a través del Consejo de Certificación de Profesionales Médicos de la Academia Nacional de Medicina, otorga la certificación a los profesionales otorrinolaringólogos que así lo soliciten, y que cumplan con determinados requisitos que se establecen en su reglamento.

Se ha conformado el Departamento de Fonoaudiología de la F.A.S.O., que, junto a la Sociedad de la Voz, intenta cubrir la necesidad de interrelación con las actividades conexas a la otorrinolaringología, organizándose cursos y talleres en nuestra sede.

La Revista de la FASO se encuentra en su decimotercer año de edición, siendo el órgano oficial de difusión. Sus cuatro adiciones anuales son enviadas a los colegas que figuran en nuestros archivos y que se encuentren al día con el aporte de las Sociedades.

En la sede de la Federación funciona la secretaría administrativa del Foro Argentino de Entidades Científicas Médicas (FADECIM), donde también lleva a cabo sus reuniones con representantes de distintas especialidades médicas, siendo la F.A.S.O. miembro de su Comité Ejecutivo.



CONGRESOS 1º Encuentro Brasilero - Argentino de ORL

La Federación Argentina de Sociedades de Otorrinolaringología (F.A.S.O.) organiza junto a la Asociación Brasilera de Otorrinolaringolologia




El 1º Encuentro Brasilero -  Argentino de ORL

Auspiciado por la Asociación Brasilera de Otorrinolaringología y Cirugía de Cabeza y Cuello
 Sociedades Federadas, Filiales y Adherentes que conforman la Federación.
gía y Cirugía de Cabeza y Cuello.

Fecha: Se llevará a cabo los días 07,08 y 09 de agosto  de Agosto de 2013-
Sede: Tanto las sesiones científicas como la exposición comercial se desarrollarán en los salones del Palais Rouge
Jerónimo Salguero 1443/49 – Ciudad Autónoma de Buenos Aires
Tel/fax: (5411) 4823-3498/, Argentina.

Sesiones científicas: Se desarrollarán bajo la forma de Conferencias, Mesas Redondas, trabajos libres y E-posters.
Secretaría administrativa:
Ángel Carranza 2382 (C1425FXF) Ciudad de Buenos Aires  Tel. / Fax: (5411) 4772-6419 / 4773-6447
eventos@faso.org.ar / jmerino@faso.org.ar
      
Secretaría de acreditaciones: Funcionará a partir del día Miércoles 07 de Agosto a las 07.00 hs. En secretaría podrá obtener su diploma de asistencia
Sitio Web: La información actualizada de este evento se podrá obtener del sitio de Internet: www.faso.org.ar
Idioma: El idioma oficial del Congreso es el Español.
Credenciales: Será entregada junto con el material informativo el día de inicio del evento. Tendrá colores o siglas distintivas de acuerdo a la categoría de inscripción para su individualización.
Deberá ser llevada constantemente en un lugar visible para permitir el acceso a la exposición comercial y a las sesiones científicas
Entrega de Certificados de asistencia: Se entregarán los certificados de asistencia SIN EXCEPCION a partir del día Jueves 08 de Agosto a las 17:00 hs. en la Secretaría de Acreditaciones del Congreso
Control de Accesos: La asistencia a las distintas actividades será controlada mediante el sistema electrónico por código de barras, debiendo cumplir un mínimo de horas Cátedra para la obtención del certificado y de créditos utilizables para el Sistema de Certificación.
El acceso será registrado en el ingreso y egreso de cada una de las sesiones del programa científico.
Créditos a los Asistentes: El consejo de acreditación dependiente de la Secretaria de Asuntos Profesionales de la Federación Argentina de Sociedades de Otorrinolaringología (FASO) ha decidido otorgar 10 créditos para los asistentes al 31º Congreso Argentino de Otorrinolaringología y Actividades Conexas , que podrán ser utilizados para la certificación profesional (CAO)
Becas de inscripción: Se recuerda a todos los colegas la decisión adoptada por los Presidentes de Sociedades: Las becas de inscripción ofrecidas por las empresas, tendrán validez solo para aquellos profesionales que se encuentren al día con el aporte a sus Sociedades.
Trabajos libres: Los trabajos completos deberán ser entregados junto al material audiovisual en la oficina receptora destinada a tal fin al menos con 4 horas de anticipación a su presentación.
La ubicación de los trabajos en programa será realizada con anterioridad por el Comité Científico, no pudiéndose realizar modificaciones en días y horarios. La presentación del resumen implica la obligatoriedad de su exposición.

Comunicaciones E-posters: El sistema e-pósters carga los nombres de todos los trabajos,  el número del mismo y los nombres de los autores de modo que el participante pueda acceder fácilmente al póster que sea de su interés.
Defensa de e-posters:
Presentación del material de los e-posters:Deberá enviarse vía mail a: eventos@faso.org.ar hasta el día 20 de julio  
Fuente: http://www.faso.org.ar/cong_ago_13/info_gral.asp

viernes, 5 de julio de 2013

CONGRESOS 74° Jornadas Rioplatenses y XI Congreso uruguayo de ORL, 26,27 y 28 de Setiembre de 2013


Acúfenos: Sección Videos: Equipo para tratar acúfenos y disfuncion ATM


¿Alguna vez has oído hablar de un misterioso "zumbido" en los oídos?  
Este trastorno, llamado tinnitus, afecta a unos 50 millones de estadounidenses - y requiere alrededor de $ 2260 millones al año en costos de tratamiento.  
Es causado por el daño a los oídos de los ruidos fuertes, y el problema es cada vez mayor en las personas menores de 20 años que están usando auriculares y reproductores de mp3 en forma regular.

Investigadores de la Universidad de Michigan están trabajando en un dispositivo para el tratamiento de la enfermedad, que se enfoca en los nervios en la mandíbula y la cara combinando sonido y  estimulación eléctrica para reducir la hiperactividad en los nervios que pueden llevar a producir tinnitus.

Acerca de la Profesora: Dr. Susan Shore (http://www2.khri.med.umich.edu/facult ...) es profesora de Otorrinolaringología, Fisiología Molecular e Integrativa e Ingeniería Biomédica (http://www.bme. umich.edu /) en la Universidad de Michigan.  
Como Directora del Laboratorio de Neurobiología Sensorial (http://www2.khri.med.umich.edu/resear ...), sus objetivos son estudiar el papel de las conexiones neuronales de otras partes del cerebro para el tronco cerebral auditivo.

Fuente:  http://www.engin.umich.edu/college/about/news/stories/2013/june/ringing-in-your-ears

jueves, 4 de julio de 2013

Acúfenos, seción fármacos experimentales, Naltrexona

Naltrexone treatment for opioid dependence: Does its effectiveness depend on testing the blockade?

  • a Columbia University and the New York State Psychiatric Institute, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
  • b Columbia University and the New York State Psychiatric Institute, 1051 Riverside Drive, Unit 51, New York, NY 10032, USA


Abstract

Background

FDA approval of long-acting injectable naltrexone (Vivitrol) for opioid dependence highlights the relevance of understanding mechanisms of antagonist treatment. Principles of learning suggest an antagonist works through extinguishing drug-seeking behavior, as episodes of drug use (“testing the blockade”) fail to produce reinforcement.
We hypothesized that opiate use would moderate the effect of naltrexone, specifically, that opiate-positive urines precede dropout in the placebo group, but not in the active-medication groups.

Methods

An 8-week, double-blind, placebo-controlled trial (N = 57), compared the efficacy of low (192 mg) and high (384 mg) doses of a long-acting injectable naltrexone (Depotrex) with placebo (Comer et al., 2006). A Cox proportional hazard model was fit, modeling time-to-dropout as a function of treatment assignment and urine toxicology during treatment.

Results

Interaction of opiate urines with treatment group was significant. Opiate-positive urines predicted dropout on placebo and low-dose, but less so on high-dose naltrexone, where positive urines were more likely followed by sustained abstinence. Among patients with no opiate-positive urines, retention was higher in both low- and high-dose naltrexone conditions, compared to placebo.

Conclusions

Findings confirm that injection naltrexone produces extinction of drug-seeking behavior after episodes of opiate use. Adequate dosage appears important, as low-dose naltrexone resembled the placebo group; opiate positive urines were likely to be followed by dropout from treatment. The observation of high treatment retention among naltrexone-treated patients who do not test the blockade, suggests naltrexone may also exert direct effects on opiate-taking behavior that do not depend on extinction, perhaps by attenuating craving or normalizing dysregulated hedonic or neuroendocrine systems.

Keywords

  • Long-acting injectable naltrexone;
  • Opiate dependence;
  • Opioid antagonist;
  • Treatment retention;
  • Urine toxicology

Figures and tables from this article:
Full-size image (62 K)
Fig. 1. (A–C) Graphical display of the treatment course of opiate-dependent patients (N = 57) in an 8-week, double-blind, placebo-controlled trial of a long-acting injection of naltrexone, comparing placebo (Fig. 1A; N = 17), low dose-192 mg naltrexone injection (Fig. 1B; N = 19), and high dose-384 mg naltrexone injection (Fig. 1B; N = 21). Each row in the figures represents the data for a patient, and the columns represent each of the 16 twice-weekly clinic visits at which urine was collected across the 8-week trial, plus an initial visit at the time of hospital discharge post-injection (Visit 0) and an extra visit (“2nd) to receive the second depot naltrexone injection, for a total of 17 visits (Visits 1–8 and 9–16). Open circles represent visits where the patient was present and gave a urine sample negative for opiates. Filled (darkened) circles represent visits where the patient was present and gave an opiate-positive urine sample. Blanks (no circle) indicate that patient was not present at that visit or did not provide a urine sample.
Full-size image (55 K)
Fig. 2. (A–C) Treatment retention as a function of opiate status of urine toxicology throughout duration of trial: all opiate-negative (1) vs. any opiate-positive urine (0). Each figure represents the survival in twice weekly study visits over the 8-week trial for participants who tested the blockade (0) vs. those who did not test (1).
Table 1. Cox proportional hazards regression model, modeling time to dropout from treatment, as a function of naltrexone treatment assignment.
Placebo (N = 17) is the reference group, against which the low dose-192 mg (N = 19), and high dose-384 mg (N = 21) conditions are contrasted. Urine toxicology, measured at twice-weekly clinic visits, was scored as a dichotomous covariate in this analysis as positive if one or more urines was positive for opioids during the trial, and negative otherwise (negative is the reference group). Values in the table are the regression coefficients for each term in the model, corresponding significance levels, and the point estimate of the hazard ration and its 95% confidence limits. The significant low-dose naltrexone-by-urine interaction term, indicates that the effect of low-dose naltrexone differs between patients with vs. without a positive urine; when urine is positive dropout is similar (and high) on low-dose naltrexone and placebo, while when urines are all negative, dropout rate is low on low-dose naltrexone (compared to high dropout on placebo) and approaches the low dropout rates for the high-dose naltrexone condition.

Corresponding author contact information
Corresponding author. Tel.: +1 212 543 6525; fax: +1 212 543 6018.
Fuente:  Drug and Alcohol Dependence

Charla gratuita: Acúfenos

Charla gratuita: Acúfenos

Jueves, 04 Julio 2013 00:43

4 de julio, a las 18.30 Hs, Quintana 161 CABA.

 A cargo del Dres. Darío Roitman (otorrinolaringólogo) y Matías Bonanni (psiquiatra)

¿Qué es ese ruido molesto en mi oído?

Hay algunas veces que repentinamente escuchamos un ruido extraño que no procede de ninguna fuente externa, como si fuera un zumbido grave o agudo, un ronroneo, un silbido, un cantar de grillos, entre otros sonidos.
Estos fenómenos son conocidos como acúfenos.

La Fundación para la Investigación en las Neurociencias Aplicadas a la Clínica (FINAC); invita el próximo jueves 4 de julio, a las 18.30 horas, a una charla grauita para conocer qué es esta problemática, sus causas y tratamientos.

Los expositores del encuentro serán el Dr. Darío Roitman, médico otorrinolaringólogo y el Dr. Matías Bonanni, médico psiquiatra.

En Av. Quintana 161, CABA.

Para inscripciones y consultas, favor llamar de lunes a viernes de 8 a 20 horas al 011-4824-1962.

FUENTE : www.inac.org.ar y www.acufeno.com

lunes, 1 de julio de 2013

Acufenos/secion causas: Estenosis bilateral del Seno Transverso en pacientes con Acufenos


pseudotumor_0.jpg 
Transverse sinus stenosis in a patient with IIH.  Left: narrowing of transverse sinuses bilaterally (arrows).  Right: Resolution of stenosis , Fuente de la Imagen: http://pedclerk.bsd.uchicago.edu/page/pseudotumor-cerebri

 

Bilateral transverse sinus stenosis in patients with tinnitus

after lumbar puncture.
Fuente de la imagen:  http://pedclerk.bsd.uchicago.edu/page/pseudotumor-cerebri

SUMMARY

Tinnitus is a frequent complaint in patients affected by intracranial hypertension (IH). Recently, some studies have reported an association between idiopathic intracranial hypertension (IIH) and bilateral transverse sinus stenosis (BTSS). We investigated the relationship between BTSS and monosymptomatic tinnitus, regardless of its clinical characteristics, in subjects without clinical evidence of IH. We selected 78 subjects (all women, mean age 49.5 ± 10.36) affected by tinnitus, without clinical history of audiological and otological pathologies, enrolled among outpatients of the Institute of Audiology and Phoniatrics in Catanzaro, Italy, over a 2 year period. All subjects underwent psychometric evaluation, psychoacoustic assessment, neurological and ophthalmological examination, cerebral magnetic resonance venography (MRV) and brain magnetic resonance imaging (MRI). MRV identified BTSS in 17.9% (14 patients). In the BTSS group, tinnitus was bilateral/central in 21%, and monolateral in the remaining patients (50% left; 29% right ear). It was more frequently pulsating in the BTSS group, but 64.9% of BTSS subjects described their tinnitus as stable. No features of tinnitus showed statistical significance in association with BTSS. In BTSS subjects, we found values suggesting IH by lumbar puncture (LP) in 40% of cases. In these patients, LP gave immediate improvement of tinnitus. The association between BTSS and tinnitus, regardless of its features, must be considered when other causes of tinnitus are excluded.
KEY WORDS: Idiopathic intracranial hypertension (IIH), Magnetic resonance venography (MRV), Bilateral transverse sinus stenosis (BTSS), Tinnitus

Introduction

Tinnitus is a common condition that affects a broad range of patients, with some uncertainties about its prevalence and incidence, and a great variety of aetiopathogenetic and diagnostic issues. Prevalence data range from 3 to 30%, without consistent findings with regard to relationship between prevalence and age or gender

Idiopathic intracranial hypertension (IIH) is a condition characterized by raised intracranial pressure without any identifiable pathology in the brain and with normal cerebrospinal fluid (CSF) composition. IIH may occur with and without papilloedema
 It predominantly affects overweight women, and while headache is the most common symptom, disturbance of vision and tinnitus are also very frequent complaints
. In particular, tinnitus is reported in 55%-60% of patients

is usually pulsatile and often occurs in one ear only. Non-pulsatile or bilateral tinnitus can also occur in some cases
Recently, a connection between bilateral transverse sinus stenosis (BTSS) and IIH with or without papilloedema

has been described. Cerebral MR venography studies have found BTSS in the majority of IIH patients, with or without papilloedema, whereas BTSS has been reported in only a few subjects with normal CSF pressure
Considering this and the well-known relationship between intracranial and cochlear fluids
 hypothesizing that an alteration of venous cerebral circulation, especially BTSS, could be the basis of onset and maintenance of monosymptomatic tinnitus in subjects without clinical evidence of elevated intracranial pressure, we investigated the frequency of association between tinnitus and BTSS and the possibility to define some specific features of tinnitus that allow us to suspect BTSS.

Material and methods

The study population consisted of 78 patients affected by tinnitus (ages 27 to 69, mean age 49.5 ± 10.36), enrolled according to selection criteria, among those admitted to Institute of Audiology and Phoniatrics in Catanzaro, Italy, over a 2 year period, starting from February 2008. We selected only females as IH affects predominantly women
 Tinnitus was diagnosed and assessed according to criteria described later.
All patients underwent otolaryngological and neurological examination, standardized clinical general examination and, as IH affects predominantly overweight women, we also included evaluation of body mass index (BMI: weight in kilograms divided by the square of height in meters)
 Examination and interviews were conducted by the same physicians.
Given the availability in literature of data about the prevalence of BTSS in normal subjects and, in this particular case, personal data already published in a previous paper
 the authors decided to make utilize these previous data without violating of ethical and economic precepts by carrying out expensive imaging exams in normal subjects.

Inclusion criteria

Female sex, tinnitus for at least two months, monosymptomatic, regardless of its characteristics, and an age between 25 and 70 years.

Exclusion criteria

Clinical history of audiological and otological pathologies (other clear causes for tinnitus, Ménière's disease, acoustic neuroma, noise-induced hearing loss, assumption of drugs inducing tinnitus
, etc.), otological surgery, were excluded. In order to exclude presbycusis, individuals with a pure-tone average over 30 dB HL for 2-4-8 kHz were not included in the study. Presence of papilloedema and abnormalities in neurological examination.

Assessment of tinnitus

We carried out careful evaluation of tinnitus that included both evaluation by questionnaires for psychometric assessment
and hyperacusisas well as psychoacoustic assessment.
Our protocol included: i) A thorough history with detailed interview; ii) questionnaire for hyperacusis
The following popper user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
 and tinnitus handicap inventory iii) physical examination; iv) pure-tone thresholds with air and bone conduction and speech audiometry; v) tinnitus test battery: tinnitus loudness and pitch matching, minimal masking levels (MML s), loudness discomfort levels (LDL s)
The following popper user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
vi) acoustic-immittance measurements with tympanometry and acoustic-reflex thresholds (only if tolerated comfortably by patient and always after the results of the hyperacusis questionnaire). We did not perform the residual inhibition test because of its controversial clinical and scientific value

Neuroimaging studies

All patients included in this study underwent brain gadolinium- enhanced magnetic resonance imaging (MRI) to exclude acoustic neuroma or other neoformative causes for tinnitus. Patients with normal MRI underwent MRV of the brain with a 1.5 T scanner (GE Medical systems, Milwaukee, WI), using three dimensional phase-contrast (PC) techniques
 All brain MRV were analyzed by the same neuroradiologists who were blinded to patient history. We classified the transverse sinus stenosis (TSS) as absent or present. BTSS was considered when the signal flow was lacking (flow gap) in the midlateral portion of both transverse sinuses.

CSF measurements

10 patients with BTSS underwent lumbar puncture to evaluate CSF opening pressure
The test was not performed in the remaining 4 patients because they denied consent.

Statistical analysis

Statistical analyses were performed using Primer® software. The statistical assessment of differences between classes was performed using Fisher's exact test and the chi-square test. A p-value < 0.05 was considered statistically significant. We also evaluated the Mantel-Haenzel odds ratio and performed multivariate logistic analysis using a multiple logistic regression model.

Results

We studied 78 subjects, all females, affected by tinnitus, regardless of its clinical characteristics, carefully ruling out specific causes.

Imaging studies

MR V identified the presence of BTSS in 14 subjects (17.9%); this was significantly different from that in subjects with normal CSF pressure (1.8%; p = 0.000734; odds ratio [OR ] = 0.0996)
In 17 patients (21.7%), the test did not highlight any specific alteration, while in the remaining 47 (60.2%) MR V detected various degrees of transverse sinus (TS) alterations (hypoplasia or asymmetry) that did not reach the level of stenosis or bilateral extension (Table I).
Table I.
MR venography results. MRV identified the presence of BTSS in 17.9% of subjects (p = 0.000734 vs. no-BTSS subjects; OR = 0.0996).
Next, we investigated the site (Table II), type (Table III), pitch (Table IV) and loudness (Table V) of tinnitus.
Table II.
Tinnitus site. Compared with the BTSS group, there was a higher frequency of bilateral/central localization of tinnitus in the no-BTTS group, as well as in normal subjects (p = 0.008717, OR = 2.4052).
Table III.
Tinnitus type. Pulsatile was more frequent for tinnitus in the BTSS group compared to the no-BTSS group (p = 0.000244, OR = 0.2532).
Table IV.
Tinnitus type. Pulsatile was more frequent for tinnitus in the BTSS group compared to the no-BTSS group (p = 0.000244, OR = 0.2532).
Table V.
THI grading. Distribution of population in different THI classes. For BTSS, the an average value was 15.14 (± 10.12), while for no-BTSS was 15.68 ± 12.99 (p, not significant).

Tinnitus site

In the BTSS group, tinnitus was bilateral/central in only 21% of cases, while it was monolateral in the remaining patients (50% left ear; 29% right ear). In the no-BTSS group, tinnitus was localized bilaterally/centrally in 39%, on the left ear in 48.4% and on the right side in 12.5% of cases. Compared to the BTSS group there was a higher frequency of bilateral/central localization of tinnitus in the global no-BTTS group, as well as in normal subjects (p = 0.008717, OR = 2.4052) (Table II).

Tinnitus temporal characteristics

Concerning the temporal characteristics of tinnitus, it was more frequently pulsating in the BTSS group compared to the no-BTSS group (p = 0.000244, OR = 0.2532) (Table III). On the other hand, we found that the majority of subjects in the BTSS group (64.9%) described their tinnitus as stable, rather than pulsatile.

Tinnitus pitch

We separated all subjects into three classes of tinnitus pitch: over 3 kHz, under 3 kHz and those not able to identify a frequency for their tinnitus. Tinnitus with pitch over 3 kHz was more frequent in both groups of patients, but the distribution, reported in Table IV, did not show any significant differences.

Other psycho-acoustic tests (Loudness, MMLs, LDLs)

No differences in tinnitus were seen in other psychoacoustic tests. In particular (mean values), tinnitus loudness was 8.1 dB SL in the BTSS group and 7.6 dB SL in the no-BTSS group; MMLs were 11.7 dB SL for the former, 12.2 dB SL for the latter. Analysis of LDLs revealed values over 90 dB for all frequencies tested in both groups, according to the results of the hyperacusis questionnaire which did not show the presence of loudness sensitivity problems.

Psychometric tests

The results of the tinnitus handicap inventory (THI)
and grading of psychometric evaluation are reported in Table V. Compared to the no-BTSS group, subjects with BTSS reported more frequently (57.1%) tinnitus that was easily masked by environmental sounds and easily forgotten with activities, that may occasionally interfere with sleep but not with daily activities. In the majority of no-BTSS subjects (67.2%), tinnitus was heard only in a quiet environment and very easily masked and had no interference with sleep or daily activities. Only few of these subjects fall in THI grade 3 (10.9%). These results did not show any statistically significant differences. The results of hyperacusis questionnaire did not show the presence of loudness sensitivity problems, according to LDL s performance.

BMI

Because of their frequent association with IH, and, hereupon, with BTSS, we also investigated for the presence of overweight and obesity (Table VI) and found no statistical significance when matched between different groups.
Table VI.
Distribution of population in different BMI classes.

CSF measurements

We found values suggesting IH
 in 40% of BTSS patients (4/10) (Table VII). Only one (# 13) of these patients referred tinnitus as pulsatile and bilateral. In the other patients, tinnitus was localized on the left and was stable. In all of 4 IH cases, LP led to immediate improvement of tinnitus.
Table VII.
Lumbar puncture results. Opening liquor pressure, normal values 65-195 mmH2O

Multivariate analysis

We also performed multivariate logistic analysis using a multiple logistic regression model considering tinnitus type and site in order to clarify the association of these variables with the presence of BTSS. The main conclusion of this analysis is that the tinnitus site (OR = 2.40) seems to be associated with the presence of BTSS. Considering the other variables, the results were inconclusive.

Discussion

Tinnitus is a common and poorly understood disorder, whose aetiopathogenesis is still under debate, and represents an enormous challenge for both otologists and neurotologists. In the present study, we hypothesize that an alteration of venous cerebral circulation, especially BTSS, might be one of the pathophysiological bases of the disease, even in absence of clinical evidence of elevated intracranial pressure. The rationale for this hypothesis relies on the potential effects of vascular abnormalities (i.e. BTSS) on the fragile homeostasis that exists between intracranial and labyrinthine fluids. In fact, several lines of clinical evidence indicate that pressure variations of intracranial fluids influence labyrinth hydromechanics causing otologic reversible symptoms such as hypoacusis, vertigo or tinnitus
. A connection between intracranial and labyrinthine fluids has been reported, albeit inconstant; the perilymph is, in fact, in direct relationship with the intracranial fluids district, throughout the cochlear aqueduct conversely, the endolymph communicates indirectly with the intracranial fluids district throughout the endolymphatic sac; the pressure homeostasis between endolymph and perilymph is maintained by the Reissner's and other labyrinthine membranes Different connections are represented by the perivascular and perineural spaces, even if this is possible only in the presence of high intracranial pressure or anatomical lesions.
Moreover, experimental demonstration of the connections between the intracranial and labyrinthine fluids has been reported in animal models, showing the absence of modifications within labyrinthine fluids if the cochlear and vestibular aqueducts were closed

The cochlear aqueduct seems to act as a low pass filter, avoiding strong and dangerous transmission of intracranial pressure variations to the labyrinthine fluids. On the other hand, it is important to underscore that the anatomical features of the cochlear aqueduct may per se lead to potential loss of efficacy, due to the progressive but variable degree of sealing throughout life. The percentage of this closure among life is reported to be very different in the literature

Nonetheless, mechanisms of reabsorption and, therefore, of pressure regulation, of cerebrospinal fluid (CF) are well known. It occurs mainly at the level of arachnoid granulations that are located, to a large extent, in transverse sinuses. The functions of these structures are CF reabsorption and its transportation in the bloodstream. A transverse sinus stenosis could influence CF reabsorption with indirect consequences on labyrinthine hydromechanics.
All these considerations, together with those on pathophysiological mechanisms of IIH, already discussed in the introduction, prompted us to consider a possible association between the BTSS and abnormal homeostasis among intracranial and cochlear fluids.
The first aim of our study was to evaluate the frequency of association between BTSS and tinnitus. For this purpose we selected subjects affected by monosymptomatic tinnitus, without clinical signs of IH. In this first step of our study, we choose to reinforce the sample to evaluate if there is some basis for our hypothesis by enrolling only female patients due to the higher incidence of IH among women
 We planned to extend our evaluation to a cohort with males in a second step.
BTSS is reported in 1.8% of subjects with normal CSF pressure
. As mentioned in the methods section, we decided to utilize personal data already published in a previous paper for ethical and economical reasons.
In our cohort, we found a significantly higher percentage (17.9%) of bilaterally abnormal transverse sinuses, therefore hypothesizing that this condition might be one of the causes of tinnitus. Given the frequent association between BTSS and IIH, we investigated if IH was present in our BTSS cases, even if without clinical evidence.
Indeed, 4 of 10 subjects that underwent LP presented values suggesting IH. Moreover, in these 4 subjects LP determined recovery from tinnitus. This allowed for two considerations: the first on therapeutic effect on tinnitus from IH treatment, and the second on need to investigate the suspect of IH in presence of monosymptomatic tinnitus without evident causes. Our second aim, consequential to the first, was to characterize some features of tinnitus linked to BTSS based on the findings of MRV.
Our results highlighted that the common association between some features of the tinnitus (e.g. pulsatility, low frequency pitch) and its "vascular" origin appears to be more unlikely. Pulsatility, in fact, was reported in only 35.9% of our BTSS group, and in just one of patients with a diagnosis of IH after LP. Thus, it cannot be considered as a criterion for the suspect of association with BTSS. This result could be explain by the subjective nature of information about tinnitus, despite careful interviews. However, in the literature there are reports that agree with this finding
 No other feature of tinnitus showed statistical significance in association with BTSS.
With reference to site of tinnitus, there is agreement between our results and literature data about the prevalence of localization on the left in both groups, as well as the more frequent bilateral localization in the no-BTSS group compared to the BTSS one
 Therefore, a potential limitation of our study is when to indicate MRV in the clinical management of patients suffering from tinnitus. MRV, as described earlier, is a fast non-invasive tool that does not necessitate the use of contrast agents. Nonetheless, at present, there are no clinical and/or instrumental features that can be used as a specific marker to address tinnitus patients to further MRV imaging studies.
On the basis of the described significant association with BTSS, we hypothesize that this venous alteration can be considered as one potential pathophysiological mechanism of tinnitus. Based on our selection criteria that excluded IH symptoms, this conclusion is also valid in subjects without clinical evidence of IH . As a consequence, monosymptomatic tinnitus maybe an important symptom if IIH without papilloedema is suspected, regardless of its features. The therapeutic effect of LP on tinnitus in subjects with IH reinforces the hypothesis of a direct influence between labyrinthine and intracranial fluids, confirming observations reported in the literature
 This allows us to underscore that tinnitus, when linked to venous stenosis and IIH , may benefit from pharmacological drugs for IH .

Acknowledgements

The authors would like to thank Pietro Hiram Guzzi for his precious contribution in statistical analysis.

References

1. Sanchez L. The epidemiology of tinnitus. Audiological Medicine. 2004;2:8–17.
2. Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49:185–193. [PubMed]
3. Bono F, Messina D, Giliberto C, et al. Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol. 2008;255:807–812. [PubMed]
4. Dhungana S, Sharrack B, Woodroofe N. Idiopathic intracranial hypertension. Acta Neurol Scand. 2010;121:71–82. [PubMed]
5. Marchbanks RJ. Hydromechanical interactions of the intracranial and intralabyrinthine fluid. In: Ernst A, Marchbanks R, Samii M, editors. Intracranial and intralabirinthine fluids: basic aspects and clinical applications. Berlin, Heidelberg: Springer Verlag; 1996. pp. 51–61.
6. Jindal M, Hiam L, Raman A, et al. Idiopathic intracranial hypertension in otolaryngology. Eur Arch Otorhinolaryngol. 2009;266:803–806. [PubMed]
7. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;60:1418–1424. [PubMed]
8. Fera F, Bono F, Messina D, et al. Comparison of different MR venography techniques for detecting transverse sinus stenosis in idiopathic intracranial hypertension. J Neurol. 2005;252:1021–1025. [PubMed]
9. Bono F, Lupo MR, Lavano A, et al. Cerebral MR venography of transverse sinuses in subjects with normal CSF pressure. Neurology. 2003;61:1267–1270. [PubMed]
10. Aronne LJ. Classification of obesity and assessment of obesity- related health risks. Obes Res. 2002;10(Suppl 2):105–115. [PubMed]
11. Cianfrone G, Pace M, Turchetta R, et al. An updated guide on drugs inducing ototoxicity, tinnitus and vertigo. Acta Otorhinolaryngol Ital. 2005;25(5 Suppl 81):3–31. [PubMed]
12. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1996;122:143–148. [PubMed]
13. Khalfa S, Dubal S, Veuillet E, et al. Psychometric normalization of a hyperacusis questionnaire. ORL J Otorhinolaryngol Relat Spec. 2002;64:436–442. [PubMed]
14. Vernon JA, Meikle MB. Tinnitus: clinical measurement. Otolaryngol Clin North Am. 2003;36:293–305. [PubMed]
15. Roberts LE. Residual inhibition. Prog Brain Res. 2007;166:487–495. [PubMed]
16. Heermann J. Predominance of left ear in Meniére's disease, sudden deafness, inner ear damage, tinnitus and abnormally patent eustachian tube. Ear Nose Throat J. 1993;72:205–208. [PubMed]
17. Sismanis A. Otologic manifestations of benign intracranial hypertension syndrome: diagnosis and management. Laryngoscope. 1987;97(8 Pt 2 Suppl 42):1–17. [PubMed]
18. Böhmer A. Hydrostatic pressure in the inner ear fluid compartments and its effects on inner ear function. Acta Otolaryngol. 1993;507:3–24. [PubMed]
19. Beentjes BI. The cochlear aqueduct and the pressure of cerebrospinal and endolabyrinthine fluids. Acta Otolaryngol. 1972;73:112–120. [PubMed]
20. Carlborg BI, Konrádsson KS, Carlborg AH, et al. Pressure transfer between the perilymph and the cerebrospinal fluid compartments in cats. Am J Otol. 1992;13:41–48. [PubMed]
fuente: 
Acta Otorhinolaryngol Ital. 2012 August; 32(4): 238–243.
PMCID: PMC3468936

Acúfenos problematicos en la infancia y adolescencia: Datos de centros de Expertos


 

Troublesome tinnitus in childhood and adolescence: Data from expert centres.


OBJECTIVE: Whilst there are several published studies of the prevalence of troublesome tinnitus in childhood and adolescence (indicating that up to a sixth may experience bothersome tinnitus), there is sparse information regarding incidence. 

METHODS: In this study a retrospective case review of patients aged under 18 with a primary complaint of tinnitus seen in 2009 was undertaken in four European clinics known to accept such referrals. 

RESULTS: A total of 88 young persons with a primary complaint of tinnitus were seen in 2009 by these services, and this represents 3.8% of the paediatric clinical workload of these services and 0.3% of the total clinical workload in that year. 

The overwhelming majority (93%) of cases were aged 10 years or over at presentation. 

In only 16 cases (18%) was the tinnitus classified as severe by the reviewing clinician. 

Tinnitus was accompanied by hyperacusis in 34 cases (39%). 

CONCLUSIONS: Whilst tinnitus in childhood or adolescence can be severe, this is rarely seen in the clinic. 

Epidemiological data for childhood tinnitus reported previously should be interpreted with caution, as it is dissonant with the data presented in the current study. 

This may represent an unmet need in the population, but it may also be the case that the incidence of tinnitus in childhood and adolescence is low.

FUENTE: International Journal of Pediatric Otorhinolaryngology 2013;Vol 77(2):248 51

Hiperacusia: acufenos e hiperacusia inducidos por una exposicion a sonido intenso

Behavioral evidence for possible simultaneous induction of hyperacusis and tinnitus following intense sound exposure.


Many human subjects suffering from chronic tinnitus also suffer from hyperacusis, a heightened perception of loudness at moderate to intense sound levels. 

While numerous studies suggest that animals develop chronic tinnitus following intense noise exposure, it is not yet clear whether sound exposure also induces chronic hyperacusis-like responses in animals. 

We addressed this question by examining the chronic effects of intense sound exposure on the acoustic startle response (ASR) and its suppression by background noise containing brief gaps. 

We compared startle amplitudes in intense tone-exposed (10 kHz, 115 dB SPL, 4 h) and age-matched controls at 2-28 weeks post-exposure. 

While both groups showed similar startle thresholds, exposed animals showed a hyperacusis-like augmentation of ASR at high stimulus levels.

 Addition of background noise had little effect on ASR in controls but had a strong suppressive effect on startle in exposed animals, indicating a sensitization to background noise. 

When the background noise contained a gap preceding the startle stimulus, ASR was suppressed in control animals, but exposed animals showed a marked weakening of gap-induced suppression of ASR. This weakening of gap-induced startle suppression is consistent with the interpretation that the gap may have been masked by tinnitus. 

The associated hyper-responsiveness to startle stimuli presented alone and the sensitization to background noise suggest that hyperacusis may have also been induced. 

The results indicate that noise exposure leads to increases in the gain of auditory responsiveness and may offer a model of the association of hyperacusis with tinnitus.

Fuente: Jaro - Journal of the Association for Research in Otolaryngology 2013;Vol 14(3):413 24

Acúfenos: Sindrome de Vogt-Koyanagi-Harada

An unusual cause of vertigo, tinnitus, and hyperacusis: Vogt-Koyanagi-Harada syndrome.


We describe the case of a 36-year-old woman with a history of vitiligo who presented with an insidious onset of neurologic, vestibular, ocular, and auditory symptoms. 
She had recently noted the onset of vertigo, tinnitus, and hypersensitivity to sound. 
Findings on audiometry were within normal limits, although the patient reported some auditory discomfort during the testing. 
The patient had a history of bilateral uveitis and peripheral neurologic symptoms. 
She was diagnosed with Vogt-Koyanagi-Harada (VKH) syndrome and started on corticosteroid therapy.

Her neurologic, vestibular, ocular, and auditory symptoms resolved. 

VKH syndrome is an uncommon cause of vertigo and hearing loss, but it should be considered in the differential diagnosis of patients with autoimmunity-related inner ear symptoms.

Fuente: ENT - Ear Nose & Throat Journal 2012;Vol 91(12):E7 9

Nota de la redacción:de acuerdo a lo que se informa en http://commons.wikimedia.org/wiki/File:VKHS.jpg

El síndrome de Vogt-Koyanagi-Harada es una enfermedad sistémica autoinmune caracterizada por la aparición de uveítis, hipoacusia, alopecia, encefalitis y vitíligo.

 La reacción inflamatoria provocada por la alteración del sistema inmunitario afecta a diversos órganos ricos en pigmentos (úvea, retina, y algunos pares craneales, causantes de la pérdida de audición).1
La enfermedad suele comenzar con un episodio febril seguido de uveitis bilateral asociada a coroiditis y neuritis óptica
Puede acompañarse de hipoacusia neurosensorial y tinnitus, vitíligo, poliosis y alopecia, y en algunos casos incluso meningitis o encefalitis.

El primero en describirlo fue un médico árabe en torno al año 940 a. C. En 1906 Vogt y en 1929 Koyanagi describieron diversas modalidades del síndrome,en pacientes que presentaban iridociclitis, meningoencefalitis asociada a vitíligo, e hipoacusia. 

Por la misma época (1926) Harada describe el cuadro de un paciente con uveítis bilateral asociada a encefalitis, adoptándose finalmente en 1951 la nomenclatura actual.
Los tres tipos principales del síndrome son:
  • Tipo I: Patología ocular sin patología de oído o dermatológica.
  • Tipo II: Patología ocular y al menos un síntoma en oídos o piel.
  • Tipo III: Patología ocular con al menos dos síntomas en otra localización.

Referencias

  1. Ramírez-Rosales Arturo, Góngora-Rivera Fernando, García-Pompermayer Mario, Rodríguez-Robles Luis, Velarde-Magaña Germá: Enfermedad de Vogt-Koyanagi-Harada: Reporte de un caso. Rev Mex Neuroci 2012; 13(5): 275-280. 
  •  VKHS.jpg 
  • The diagnostic clue in this patient is the telltale loss of hair coloring in the left eyebrow and eyelashes (poliosis) with contiguous vitiligo. 
  • Additional features of this syndrome—all of which this patient had—include panuveitis, retinal detachment, pinpoint retinal leaks on fluorescein angiography, and evidence of auditory and central nervous system dysfunction, including aseptic meningitis. 
  • Decreased visual acuity is the rule. The cause is uncertain, but immune-mediated damage of melanocyte-containing tissue seems likely. 
  • Long-term corticosteroid therapy usually halts further ocular damage and often improves vision.

Acúfenos: Farmacologia, El uso de la Naltrexona en la percepcion y el disconfort de los acúfenos

The effect of naltrexone on the perception and distress in tinnitus: an open-label pilot study.


Objective: Tinnitus is a perceived sensation of sound without actual acoustic stimulation. 
Currently there are no standardized drug therapies for the treatment of tinnitus patients. 
A potential novel treatment for chronic tinnitus is naltrexone.
 Tinnitus can be considered an auditory phantom phenomenon similar to phantom pain. 
Naltrexone acts predominantly on µ-opioid receptors which are present in multiple areas of the brain, including the thalamus, dorsal part of the anterior cingulate, insula, amygdala, nucleus accumbens, and ventromedial to orbitofrontal cortex. 
These areas overlap with the areas involved in tinnitus-related distress. 
The aim of the present study is to investigate three doses of naltrexone, namely 5, 12.5, and 50 mg and determine their influence on tinnitus complaints. 
We conducted a 4-week single-center, open-label treatment study. 
Subjects and methods: 86 patients received the drug treatment, while 30 patients received no treatment

 Results: Overall tinnitus distress was significantly reduced for the drug treatment group, while for the waiting control group this was not the case. 
No significant effect could be obtained for tinnitus intensity. 
A closer look at the data indicates that this effect is mainly generated due to a significant difference in the 50 mg drug treatment group for tinnitus distress. 

Conclusion: our results indicate that naltrexone might have an effect on tinnitus distress and more particularly higher doses of naltrexone.

Fuente. International Journal of Clinical Pharmacology and Therapeutics 2013;Vol 51(1):5 11

Importancia de la cía auditivacentral en el acúfeno tonal crónico.

Acute Transient Bilateral Deafness and Reversible Bilateral Loss of Chronic Tinnitus in Sequential Bilateral MCA Ischaemic Stroke



A 67-year-old patient had a right ischaemic stroke involving the right temporal and central cortex years ago resulting in a left-sided spastic hemiparesis. 
He presented to the emergency department after having noticed acute deafness. 
At the same time, a chronic tonal binaural tinnitus subsided completely. 
Cranial MRI and FDG-PET imaging showed a chronic fronto-temporo-parietal right ischaemic stroke and a recent stroke in the rear area of the left insular cortex and the upper temporal lobe. 
The condition remained stable for 3 days and hearing started to return during MRI. 
With improvement of hearing after the MRI binaural tinnitus started again with a different character resembling the noise of the MRI machine. 
A continuous improvement of hearing was observed over the following days and within one week the patient was able to communicate without problems except when exposed to acustic stimuli from several directions at the same time. 
On follow-up 2 months later, the tinnitus had persisted without change of character while hearing was undisturbed for normal conversation. 

Loss and recurrence of the chronic tinnitus during the second ischaemic stroke in the temporal lobe point to the functional relevance of the central auditory system for the chronic tonal tinnitus.

A growing number of functional imaging and neurophysiological studies demonstrate the importance of the central auditory system within the cerebral hemispheres for the occurrence of a chronic tonal tinnitus.

Fuente: Aktuelle Neurologie 2012;Vol 39(10):563 565